MSMarco Stadler

Marco Stadler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marco Stadler has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biological Profiling of Semisynthetic C19-Functionalized Ferruginol and Sugiol Analogues

    by Miguel A. González-Cardenete, Fatima Rivas, Rachel Basset, Marco Stadler, Steffen Hering, José M. Padrón, Ramón J. Zaragozá, María Auxiliadora Dea-Ayuela

    The abietane-type diterpenoids are significant bioactive compounds exhibiting a varied range of pharmacological properties. In this study, the first synthesis and biological investigation of the new abietane-diterpenoid (+)-4-epi-liquiditerpenoid acid (8a) together with several of its analogs are reported. The compounds were generated from the readily available methyl callitrisate (7), which was obtained from callitrisic acid present in Moroccan Sandarac resin. A biological evaluation was conducted to determine the effects of the different functional groups present in these molecules, providing basic structure–activity relationship (SAR) elements. In particular, the ferruginol and sugiol analogs compounds 10–16 were characterized by the presence of a phenol moiety, higher oxidization states at C-7 (ketone), and the hydroxyl, methyl ester or free carboxylic acid at C19. The biological profiling of these compounds was investigated against a panel of six human solid tumor cell lines (HBL-100, A549, HeLa, T-47D, SW1573 and WiDr), four parasitic Leishmania species (L. donovani, L. infantum, L. guyanensis and L. amazonensis) and two malaria strains (3D7 and K1). Furthermore, the capacity of the compounds to modulate gamma-aminobutyric acid type A (GABAA) receptors (α1β2γ2s) is also described. A comparison of the biological results with those previously reported of the corresponding C18-functionalized analogs was conducted.


  • Synthesis and Biological Studies of (+)-Liquiditerpenoic Acid A (Abietopinoic Acid) and Representative Analogues: SAR Studies

    by Damir Hamulić, Marco Stadler, Steffen Hering, José M. Padrón, Rachel Bassett, Fatima Rivas, Marco A. Loza-Mejía, M. Auxiliadora Dea-Ayuela, Miguel A. González-Cardenete

    The first semisynthesis and biological profiling of the new abietane diterpenoid (+)-liquiditerpenoic acid A (abietopinoic acid) (7) along with several analogues are reported. The compounds were obtained from readily available methyl dehydroabietate (8), which was derived from (−)-abietic acid (1). Biological comparison was conducted according to the different functional groups, leading to some basic structure–activity relationships (SAR). In particular, the ferruginol and sugiol analogues 7 and 10–16 were characterized by the presence of an acetylated phenolic moiety, an oxidized C-7 as a carbonyl, and a different functional group at C-18 (methoxycarbonyl, carboxylic acid, and hydroxymethyl). The biological properties of these compounds were investigated against a panel of six representative human tumor solid cells (A549, HBL-100, HeLa, SW1573, T-47D, and WiDr), five leukemia cellular models (NALM-06, KOPN-8, SUP-B15, UoCB1, and BCR-ABL), and four Leishmania species (L. infantum, L. donovani, L. amazonensis, and L. guyanensis). A molecular docking study pointed out some targets in these Leishmania species. In addition, the ability of the compounds to modulate GABAA receptors (α1β2γ2s) is also reported. The combined findings indicate that these abietane diterpenoids offer a source of novel bioactive molecules with promising pharmacological properties from cheap chiral-pool building blocks.


  • Open Access

    Synthesis and biological screening of analogues of bioactive acid constituents from the traditional Chinese medicinal plant Liquidambar Formosana

    by Miguel A. González-Cardenete, Damir Hamulić, Marco Stadler, Steffen Hering, José Padrón, Rachel Bassett, Fatima Rivas, Maria Auxiliadora Dea-Ayuela

    Liquidambar formosana (also known as maple) is a tall deciduous tree widely distributed in various regions of the South of the Qinling Mountains and Huaihe River in China, and also found in Northern Vietnam, Laos and South Korea. L. formosana is a famous ornamental plant for leaves are green in spring and summer, and red in autumn. Different plant parts of L. formosana, such as leaf, fruit, bark, and resin, are proved to be treasures as natural medicinal plant resources [1]. Among the bioactive constituents, several diterpenoid acids of the abietane family have been identified. Abietic acid (1) occurs in plants of the genus Abies and is the first member of a class of plant metabolites, the abietane-type diterpenoids. They are characterized by a tricyclic ring system and have shown a wide range of chemical diversity and biological activity.[2,3] Medicinal chemists have studied derivatives of two readily available materials such as dehydroabietic acid (2) and dehydroabietylamine (3, DHAA).[3] To date, there is only one commercial drug, Ecabet® [ecabet sodium (4)], based on abietanes, which is used for the treatment of reflux esophagitis and peptic ulcer disease. Ferruginol (5) exhibits anticancer effects in human ovarian cancer and inhibition of cancer cell migration. Recent studies of sugiol (6) demonstrated in vivo antitumor activity in DU145 prostate xenografts. These biological reports and the simultaneous isolation, (in 2014) by Hua and co-workers, of the new abietane liquiditerpenoic acid A (7), a sugiol analogue, from the resin of Liquidambar formosana [4] and from Pinus massoniana,[5] by Kuo and co-workers named independently as abietopinoic acid, prompted us to synthesize it and study its biological properties along with some analogues. References [1] Ouyang, X. L.; Yi, S.; Lu, H. Y.; Wu, S. M.; Zhao, H. Q. Eur. J. Med. Plants 2016, 17, 1-11. [2] For a review on this topic, see: González, M. A. Nat. Prod. Rep. 2015, 32, 684-704. [3] For a review on this topic, see: González, M. A. Eur. J. Med. Chem. 2014, 87, 834-842. [4] Shang, H.-J.; Li, D.-Y.; Wang, W.-J.; Li, Z.-L.; Hua, H.-M. Nat. Prod. Res. 2014, 28, 1-6. [5] Mohamed, H. A.; Hsieh, C.-L.; Hsu, C.; Kuo, C.-C.; Kuo, Y.-H. Helv. Chim. Acta 2014, 97, 1146-1151.

  • Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABA A ) Receptor Modulators

    by Marco Stadler, Serena Monticelli, Thomas Seidel, Denise Luger, Isabella Salzer, Stefan Boehm, Wolfgang Holzer, Christoph Schwarzer, Ernst Urban, Sophia Khom, et al.

    Subunit-selective modulation of γ-aminobutyric acid type-A-receptors (GABAAR) is considered to exert fewer side effects compared to unselective clinically used drugs. Here, the β2/3 subunit-selective GABAAR modulators valerenic acid (VA) and loreclezole (LOR) guided the synthesis of novel subunit-selective ligands with simplified structures. We studied their effects on GABAARs expressed in Xenopus laevis oocytes using two-microelectrode voltage clamp technique. Five compounds showed significantly more efficacious modulation of GABA-evoked currents than VA and LOR with retained potency and selectivity. Compound 18 [(E)-2-cyano-3-(2,4-dichlorophenyl)but-2-enamide] induced the highest maximal modulation of GABA-induced chloride currents (Emax: 3114 ± 242%), while 12 [(Z)-3-(2,4-dichlorophenyl)but-2-enenitrile] displayed the highest potency (EC50: 13 ± 2 µM). Furthermore, in hippocampal neurons 12 facilitated phasic and tonic GABAergic inhibition and in vivo studies revealed significantly more potent protection against pentylenetetrazole (PTZ)-induced seizures compared to VA and LOR. Collectively, compound 12 constitutes a novel, simplified and subunit-selective GABAAR modulator with low-dose anticonvulsant activity.


  • HPLC-Based Activity Profiling for GABAA Receptor Modulators in Searsia pyroides Using a Larval Zebrafish Locomotor Assay

    by Fahimeh Moradi-Afrapoli, Hannes van der Merwe, Maria De Mieri, Anke Wilhelm, Marco Stadler, Pieter C. Zietsman, Steffen Hering, Kenneth Swart, Matthias Hamburger

    A dichloromethane extract from leaves of Searsia pyroides potentiated gamma aminobutyric acid-induced chloride currents by 171.8 ± 54% when tested at 100 µg/mL in Xenopus oocytes transiently expressing gamma aminobutyric acid type A receptors composed of α 1 β 2 γ 2s subunits. In zebrafish larvae, the extract significantly lowered pentylenetetrazol-provoked locomotion when tested at 4 µg/mL. Active compounds of the extract were tracked with the aid of HPLC-based activity profiling utilizing a previously validated zebrafish larval locomotor activity assay. From two active HPLC fractions, compounds 1 – 3 were isolated. Structurally related compounds 4 – 6 were purified from a later eluting inactive HPLC fraction. With the aid of 1H and 13C NMR and high-resolution mass spectrometry, compounds 1 – 6 were identified as analogues of anacardic acid. Compounds 1 – 3 led to a concentration-dependent decrease of pentylenetetrazol-provoked locomotion in the zebrafish larvae model, while 4 – 6 were inactive. Compounds 1 – 3 enhanced gamma aminobutyric acid-induced chloride currents in Xenopus oocytes in a concentration-dependent manner, while 4 – 6 only showed marginal enhancements of gamma aminobutyric acid-induced chloride currents. Compounds 2, 3, and 5 have not been reported previously. * Dedicated to Professor Dr. Max Wichtl in recognition of his outstanding contribution to pharmacognosy research.


  • Open Access

    Antiproliferative Activity and Effect on GABAA Receptors of the Abietane Diterpenoid Jiadifenoic Acid C and Other Callitrisic Acid (4-Epidehydroabietic Acid) Derivatives

    by Miguel A. González-Cardenete, José Padrón, Marco Stadler

    At present, about fifty percent of commercial pharmaceutical drugs are derived from natural sources. The abietane-type and related diterpenoids are a class of naturally occurring terpenoids in the plant kingdom, which have demonstrated a wide range of biological activities against cancer, and a variety of infectious diseases (viral and bacterial). Several research groups have explored the potential as chemotherapeutic agents of abietanes by means of semisynthetic derivatives from abietic acid-derived materials such as dehydroabietic acid (DHA), and dehydroabietylamine, also called leelamine. For example, DHA displays not only antiulcer and antimicrobial properties, but also antitumor effects. Recently, DHA was reported as a positive GABAA receptor modulator (potentiation of IGABA 682.3% at 100 mM). DHA displays an equatorial carboxylic group located at C18 while in other natural congeners the carboxylic group adopts the axial configuration (C19) as in 4-epidehydroabietic acid or callitrisic acid. Recently, a series of related acids having a C19 carboxylic group have been isolated. For example, the jiadifenoic acids A-I. These have shown antiviral properties against Coxsackie virus. We have developed the synthesis of jiadifenoic acid C from callitrisic acid isolated from Sandarac resin. The ready availability of these acids from our work and the absence of their biological and pharmacological studies as well as chemical manipulation prompted us to carry out this research. In this study, we carried out the synthesis of several derivatives of callitrisic acid, including jiadifenoic acid C, methyl callitrisate and callitrisinol together with evaluation of their antiproliferative and modulating GABAA receptor activities. Thus, we were able to compare with the DHA series. Biological results showed that the studied callitrisic derivatives (functionalization at C19) were less potent GABAA-modulating molecules (potentiation of IGABA 269-311% at 100 mM) than DHA (carboxyl at C18), of which jiadifenoic acid C having an allylic alcohol instead of an isopropyl moiety was practically inactive. On the other hand, functional group manipulation at C19 led to more potent antiproliferative derivatives (GI50= 3.4-61 mM) than their corresponding C18-functionalized congeners.